Reveal the top 5 cards of your deck. This attack does 80 damage for each Energy card you find there. Then, discard those Energy cards and shuffle the other cards back into your deck.
Discard all Energy from this Pokémon.
Brilliant Stars was released in 2022. Series classification for this set is Sword & Shield.
The checklist contains 186 cards, placing it in a large expansion range. As of 2026, the set is 4 years old and sits in a modern-era collecting window.
In the Brilliant Stars checklist, Infernape occupies position #26 as a Rare Holo card.
In 2022, Brilliant Stars introduced this print of Infernape. Card flavor text reads: "It tosses its enemies around with agility.
It uses all its limbs to fight in its own unique style." Its card type is Pokémon. The rarity label is Rare Holo.
Printed HP is 150. Energy typing is Fire.
As an evolution, Infernape develops from Monferno. The printed attacks highlight "Infernal Vortex" and "Burning Kick".
Current market pricing for Infernape (Brilliant Stars) sits near $0.19. Price action is stable over 7 days, moving only 0.0%.
Current value is elevated versus the 30-day mean ($0.18), by 5.6%. Its 90-day trading band runs between $0.13 and $0.20, producing a 37% range and moderate-volatility behavior.
This version is categorized as Rare Holo.
A wider Infernape checklist helps contextualize this specific Infernape print. Comparable entries in this snapshot: 6 cards, 5 distinct sets.
In this sample, pricing ranges between $0.12 and $10.04 (8267% total span). Relative to the alternative average ($2.80), this card is -93%.
Notable alternatives include Infernape #20 (Steam Siege) at $0.54, Infernape #116 (Scarlet & Violet Black Star Promos) at $3.68, Infernape #33 (Twilight Masquerade) at $0.12, and Infernape #173 (Twilight Masquerade) at $10.04.
Pricing context for collectors: Short-term movement is stable (0.0% over 7 days), with price action clustered near recent averages. With a 37% 90-day spread ($0.13-$0.20), this card currently tracks as moderate-volatility.
Current value is 5.6% above its 30-day reference ($0.18). Condition sensitivity is substantial: PSA 10 carries a +17268% premium over raw value.
PSA 9 is currently around $6.52, while PSA 10 is $33.00.
